Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion
Author:
Publisher
SLACK, Inc.
Subject
Ophthalmology,Surgery
Reference13 articles.
1. 1. Greenberg PB Martidis A Rogers AH Duker JS Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002;86:247-248.
2. 2. Ip MS Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol. 2002; 120: 12171219.
3. 3. Jonas JB Kreissig I Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:782-783.
4. 4. Park CH Jaffe GJ Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol. 2003;136:419-425.
5. 5. Ip MS Gottlieb JL Kahana A et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131-1136.
Cited by 423 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability;Expert Opinion on Drug Metabolism & Toxicology;2024-09-11
2. Clinical features, management, and outcomes of patients with sterile endophthalmitis associated with intravitreal bevacizumab injection: retrospective case series;International Ophthalmology;2024-05-05
3. Investing in vision: Innovation in retinal therapeutics and the influence on venture capital investment;Progress in Retinal and Eye Research;2024-03
4. Introduction of Diabetic retinopathy and principles of treatment;Therapeutic Targets for Diabetic Retinopathy;2024
5. Real world experience of Brolucizumab in recurrent macular oedema in Retinal Vein Occlusions : 12 months follow up;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3